Back to top
more

Roche Holding (RHHBY)

(Delayed Data from OTC)

$38.54 USD

38.54
1,076,148

+0.34 (0.89%)

Updated Jul 24, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 20% (201 out of 250)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for RHHBY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Roche Holding AG falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 11,707 10,235 14,257 13,155 11,935
Receivables 12,276 12,162 11,823 10,830 10,508
Notes Receivable 0 0 0 0 0
Inventories 8,632 9,017 8,441 7,673 6,094
Other Current Assets 4,641 4,022 4,458 3,477 2,920
Total Current Assets 37,256 35,436 38,980 35,136 31,457
Net Property & Equipment 24,198 24,180 25,343 23,634 22,317
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 7,666 6,735 6,108 5,823 5,245
Intangibles 26,976 21,487 25,083 22,682 20,949
Deposits & Other Assets 3,323 3,348 4,124 3,414 2,510
Total Assets 100,772 92,373 101,004 91,875 83,631
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 4,818 4,774 5,073 4,395 3,847
Current Portion Long-Term Debt 4,901 4,150 16,545 4,262 1,706
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 2,514 3,340 3,284 3,924 3,863
Other Current Liabilities 15,419 16,280 17,128 14,511 14,860
Total Current Liabilities 27,651 28,544 42,031 27,093 24,276
Mortgages 0 0 0 0 0
Deferred Taxes/Income 661 676 687 377 300
Convertible Debt 0 0 0 0 0
Long-Term Debt 27,635 22,416 17,589 10,901 12,750
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 7,774 7,190 9,685 11,083 10,205
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 63,721 58,825 69,992 49,453 47,531
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 119 112 175 171 161
Capital Surplus 0 0 0 0 0
Retained Earnings 47,170 40,802 37,376 48,606 40,787
Other Equity -10,238 -7,366 -6,538 -6,355 -4,848
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 37,052 33,549 31,012 42,422 36,100
Total Liabilities & Shareholder's Equity 100,772 92,373 101,004 91,875 83,631
Total Common Equity 37,052 33,549 31,012 42,422 36,100
Shares Outstanding NA 6,830.00 6,830.00 6,848.40 6,848.40
Book Value Per Share -0.37 4.91 4.54 6.19 5.27

Fiscal Year End for Roche Holding AG falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 -99,999 11,707 -99,999 8,353
Receivables NA NA 12,276 NA 12,335
Notes Receivable NA NA 0 NA NA
Inventories NA NA 8,632 NA 9,451
Other Current Assets NA NA 4,641 NA 4,318
Total Current Assets NA NA 37,256 NA 34,458
Net Property & Equipment NA NA 24,198 NA 25,354
Investments & Advances NA NA 0 NA NA
Other Non-Current Assets NA NA 0 NA NA
Deferred Charges NA NA 7,666 NA 7,416
Intangibles NA NA 26,976 NA 21,906
Deposits & Other Assets NA NA 3,323 NA 3,492
Total Assets NA NA 100,772 NA 93,853
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA NA 0 NA NA
Accounts Payable NA NA 4,818 NA 4,511
Current Portion Long-Term Debt NA NA 4,901 NA 5,608
Current Portion Capital Leases NA NA 0 NA NA
Accrued Expenses NA NA 0 NA NA
Income Taxes Payable NA NA 2,514 NA 3,978
Other Current Liabilities NA NA 15,419 NA 15,057
Total Current Liabilities NA NA 27,651 NA 29,154
Mortgages NA NA 0 NA NA
Deferred Taxes/Income NA NA 661 NA 746
Convertible Debt NA NA 0 NA NA
Long-Term Debt NA NA 27,635 NA 22,632
Non-Current Capital Leases NA NA 0 NA NA
Other Non-Current Liabilities NA 7,774 NA 7,567
Minority Interest (Liabilities) NA NA 0 NA NA
Total Liabilities NA NA 63,721 NA 60,099
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA NA 0 NA NA
Common Stock (Par) NA NA 119 NA 119
Capital Surplus NA NA 0 NA NA
Retained Earnings NA NA 47,170 NA 42,642
Other Equity NA NA -10,238 NA -9,006
Treasury Stock NA NA 0 NA NA
Total Shareholder's Equity NA NA 37,052 NA 33,755
Total Liabilities & Shareholder's Equity NA NA 100,772 NA 93,853
Total Common Equity 0 0 37,052 0 133,754
Shares Outstanding NA NA NA NA 6,830.00
Book Value Per Share 0.00 0.00 -0.37 0.00 19.58